Navigation Links
Pre-eclampsia rates on the rise in the US
Date:11/21/2013

November 20, 2013 -- A latest study by researchers at the Mailman School of Public Health and Columbia University Medical Center reports that pre-eclampsia, characterized by an elevation in the blood pressure and excess protein in the urine of pregnant women, has a 1.5-fold to 2-fold higher incidence in first pregnancies. The condition, which causes complications in approximately 3-6% of all pregnancies, is also associated with high risks of preterm delivery, intrauterine growth restriction, placental abruption, and perinatal mortality. Findings are published online in the British Medical Journal.

The study by Drs. Cande Ananth, Katherine Keyes, and Ronald Wapner in the Departments of Epidemiology and Obstetrics and Gynecology, examined data on 120 million births in the United States between 1980 and 2010 from national hospital discharge surveys. This is the largest cohort study to analyze changes in rates of pre-eclampsia in the U.S.

According to findings, pre-eclampsia rates rose from 3.4% in 1980 to 3.8% in 2010. This increase was due to the rise in rates of severe pre-eclampsia -- from 0.3% in 1980 to 1.4% in 2010, a relative increase of 322%. At the same time, rates of mild pre-eclampsia declined, from 3.1% in 1980 to 2.5% in 2010. Women born in the mid-1970s were at increased risk for mild pre-eclampsia, whereas women born in the more recent periods showed an increased risk of severe pre-eclampsia, suggesting a birth cohort effect. The researchers note that the increasing obesity and decreasing smoking rates in the United States across the last three decades explain, at least in part, the trends in the observed pre-eclampia rates.

Why the study is newsworthy:

  • The researchers analyzed data collected across 30 years to understand the association of maternal age with time of disease occurrence and mother's date of birth on rates of pre-eclampsia.

  • Results suggest that reducing obesity rates could also be favorable to a reduction in pre-eclampsia rates.


'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related biology news :

1. Nottingham researchers lead worlds largest study into pre-eclampsia
2. Study demonstrates cells can acquire new functions through transcriptional regulatory network
3. Intensive kidney dialysis indicates better survival rates than conventional dialysis
4. Culturally sensitive research in United Arab Emirates pinpoints indoor air quality risks
5. Special issue of the EMBO Journal celebrates 30 years of Wnt research
6. By adding VSL#3 probiotic to traditional therapies UC patients can improve remission rates
7. New method generates cardiac muscle patches from stem cells
8. New study demonstrates the role of urban greenery in CO2 exchange
9. WALTHAM® demonstrates commitment to scientific dialogue and exchange at international human animal interaction conference
10. Published clinical trial demonstrates efficacy of Sea-Band® for migraine-related nausea
11. Weight-loss clinic drop-out rates are a huge barrier to treating obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology: